secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2023-06-05T23:59:59+00:00
Accession:  0001477932-23-004228
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx prices $16.5M public offering of 13M shares at $1.27 per share
-------------------------------------------------------------------------

- Gross proceeds of $16.5M from 13M shares at $1.27/share; net proceeds ~$15.4M.
- Underwriters granted 30-day option to buy up to 1.95M additional shares at same price.
- Net proceeds for R&D, clinical studies, commercialization, working capital, and possible M&A.
- Underwriter warrants issued to buy up to 448,500 shares at $2.00/share, exercisable after 6 months.
- Offering expected to close on June 5, 2023, subject to customary conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793223004228/0001477932-23-004228-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793223004228/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-004228

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer